Total raised
—
Last: Seed 2018-08
Stage
Seed
Founded
2016
Headcount
2
HQ
Qatsrin
Sector
Health Tech & Life Sciences
About
InVatin Technologies has developed SYNAXIS-XT, an aortic arch uni-axial diverter designed to deliver embolic protection to the three arteries ascending from the aortic arch, thereby minimizing the risk for cerebral ischemic stroke. The company's device provides a mechanical barrier, redirecting the emboli away from the brain while preserving blood flow patterns and maintaining uncompromised stent patency. This technology can help prevent stroke in high-risk patients, regardless of the origin of the embolic substance.
Funding history · 1 round · — total
2018-08
Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary product developed by Invatin Technologies?
- Invatin Technologies has developed SYNAXIS-XT, an aortic arch uni-axial diverter designed for embolic protection to minimize the risk of cerebral ischemic stroke.
- When was Invatin Technologies founded?
- Invatin Technologies was founded in March 2016.
- What is the current operational status of Invatin Technologies?
- Invatin Technologies is currently inactive, having ceased operations in March 2022.
- How many employees does Invatin Technologies have?
- Invatin Technologies has 2 employees.
- What was the last funding round for Invatin Technologies?
- Invatin Technologies completed a Seed funding round in August 2018, with G.O Innovation as an investor.
- Who is a founder of Invatin Technologies?
- Dr. Udi Nussinovitch is a founder of Invatin Technologies.
- What is the primary sector of Invatin Technologies?
- Invatin Technologies operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.
- Has Invatin Technologies published any research or news?
- Yes, a feasibility study titled 'Novel Embolic Protection Device' was published on PubMed in November 2019.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B
Highlights
1 PatentsVerified
Tags
cardiovascularhospitalsmedical-technologiesdoctorsmedical-devicescardiologystentsurgerystrokeprevention